Form 4 for NTRA Natera, Inc.
Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-07 · accession 0001646649-25-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-12 | 2025-11-07 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $192.56 | -3,070 | 233.5K | -1% | -$591.2K |
| MI | 2025-11-12 | 2025-11-11 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $207.96 | -1,500 | 25.3K | -6% | -$311.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-07 | S | D | 100 | $198.38 | 232,660 | D | — | — | (F1) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2024. |
| 2 | Common | Common Stock | 2025-11-11 | S | D | 205 | $206.86 | 25,827 | I By Caraluna 1 Trust | — | — | (F7) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. (F8) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.68 to $207.12 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F9) Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities. |
| 3 | Common | Common Stock | 2025-11-11 | S | D | 382 | $207.95 | 25,445 | I By Caraluna 1 Trust | — | — | (F7) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. (F10) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.89 to $208.58 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F9) Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities. |
| 4 | Common | Common Stock | 2025-11-11 | S | D | 163 | $209.28 | 25,282 | I By Caraluna 1 Trust | — | — | (F7) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. (F11) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.18 to $209.29 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F9) Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities. |
| 5 | Common | Common Stock | 2025-11-11 | S | D | 190 | $206.86 | 25,842 | I By Caraluna 2 Trust | — | — | (F7) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. (F12) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.68 to $207.12 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F9) Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities. |
| 6 | Common | Common Stock | 2025-11-11 | S | D | 390 | $207.94 | 25,452 | I By Caraluna 2 Trust | — | — | (F7) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. (F13) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.89 to $208.58 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F9) Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities. |
| 7 | Common | Common Stock | 2025-11-07 | S | D | 600 | $196.06 | 232,860 | D | — | — | (F1) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2024. (F6) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.76 to $196.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 8 | Common | Common Stock | 2025-11-07 | S | D | 100 | $196.78 | 232,760 | D | — | — | (F1) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2024. |
| 9 | Common | Common Stock | 2025-11-07 | S | D | 1,480 | $190.33 | 234,250 | D | — | — | (F1) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2024. (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.00 to $190.94 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 10 | Common | Common Stock | 2025-11-07 | S | D | 90 | $191.04 | 234,160 | D | — | — | (F1) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2024. (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.00 to $191.09 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 11 | Common | Common Stock | 2025-11-07 | S | D | 400 | $192.64 | 233,760 | D | — | — | (F4) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.31 to $192.80 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 12 | Common | Common Stock | 2025-11-07 | S | D | 300 | $193.59 | 233,460 | D | — | — | (F1) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2024. (F5) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.58 to $193.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 13 | Common | Common Stock | 2025-11-11 | S | D | 170 | $209.28 | 25,282 | I By Caraluna 2 Trust | — | — | (F7) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. (F14) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.18 to $209.29 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F9) Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities. |